Genetic basis for clinical expression in multiple sclerosis
The Multiple Sclerosis Genetics Group, Stephen L. Hauser(University of California, San Francisco), Jonathan L. Haines(Vanderbilt University), A. J. Green(University of California, San Francisco), Patricia Bucher(University of California, San Francisco), Margaret A. Pericak‐Vance(University of Miami), Lisa F. Barcellos(University of California, San Francisco), Jorge R. Oksenberg(University of California, San Francisco), Jacqueline Rimmler(Duke Medical Center), Silke Schmidt(Universitätsmedizin Greifswald), M. Garcia(Vanderbilt University), Robin Lincoln(University of California, San Francisco)
Cited by 155
Related Papers
Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration
|Science|2005|2.4k
Ofatumumab versus Teriflunomide in Multiple Sclerosis
|New England Journal of Medicine|2020|683